Patent details

EP2046323 Title: COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

Basic Information

Publication number:
EP2046323
PCT Application Number:
PCT/US/2007/074036
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077997427
PCT Publication Number:
WO/2008/016793
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
French Title of Invention:
COMPOSITIONS POUR CONTRIBUER AU TRAITEMENT DES CANCERS
German Title of Invention:
ZUR TUMORBEHANDLUNG BEITRAGENDE ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
20/07/2007
Grant date:
13/02/2013
EP Publication Date:
13/02/2013
PCT Publication Date:
07/02/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/04/2009
EP B1 Publication Date:
13/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/07/2013
Expiration date:
20/07/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/07/2007
 
 

Name:
Spectrum Pharmaceuticals Inc.
Address:
157 Technology Drive, Irvine, CA 92618, United States (US)

Name:
The Board of Trustees of the
Address:
352 Henry Administration Building 506 South Wright Street, Urbana Illinois 61801, United States (US)

Inventor

1

Name:
REDDY Guru
Address:
United States (US)

2

Name:
GULATI Anil
Address:
United States (US)

3

Name:
LENAZ Luigi
Address:
United States (US)

Priority

Priority Number:
461961
Priority Date:
02/08/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/337;
Filing date Document type Number of pages